Moving cannabis to Schedule III, where it would exist among ketamine and anabolic steroids, would highlight its accepted medical uses and a lower potential for abuse.

Citing five anonymous sources familiar with the situation, the AP said the DEA’s proposal still requires review by the White House Office of Management and Budget (OMB), as well as a public comment period.